Moreno, N., Holsten, T., Mertins, J., Zhogbi, A., Johann, P., Kool, M., . . . Kerl, K. (2017). Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors. Oncotarget.
シカゴスタイル引用形Moreno, Natalia, Till Holsten, Julius Mertins, Annabelle Zhogbi, Pascal Johann, Marcel Kool, Michael Meisterernst, , Kornelius Kerl. "Combined BRD4 and CDK9 Inhibition As a New Therapeutic Approach in Malignant Rhabdoid Tumors." Oncotarget 2017.
MLA引用形式Moreno, Natalia, et al. "Combined BRD4 and CDK9 Inhibition As a New Therapeutic Approach in Malignant Rhabdoid Tumors." Oncotarget 2017.
警告: この引用は必ずしも正確ではありません.